Mechanisms of carvedilol-induced [Ca2+]i rises and death in human hepatoma cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 376, Issue 3, 2007, Pages 185-194

  Cheng, Jin Shiung ^a   Huang, Chorng Chih ^b   Chou, Chiang Ting ^c   Jan, Chung Ren ^c  

^a Yongkang Veterans Hospital   (Taiwan)

^b TZU HUI INSTITUTE OF TECHNOLOGY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Ca2+; Carvedilol; Fura 2; Hepatoma cells

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CALCIUM ION; CARVEDILOL; ECONAZOLE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FLUORESCENT DYE; FURA 2; LANTHANUM; MANGANESE; NIFEDIPINE; PHOSPHOLIPASE C; THAPSIGARGIN;

APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM; EXTRACELLULAR CALCIUM; HEPATOMA CELL; HUMAN; HUMAN CELL;

ADRENERGIC BETA-ANTAGONISTS; APOPTOSIS; CALCIUM; CARBAZOLES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; CHELATING AGENTS; CYTOSOL; EGTAZIC ACID; FLUORESCENT DYES; HEPATOCYTES; HUMANS; PROPANOLAMINES; TYPE C PHOSPHOLIPASES;

EID: 35649024855     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0191-5     Document Type: Article

References (44)

1. Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D'Alessio A, Sirabella R, Secondo A, Sibaud L, Di Renzo GF (2003) Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol Lett 139:125-133
2. Berridge MJ (1993) Inositol trisphosphate and calcium signaling. Nature 361:315-325
3. Berridge MJ (1997) Elementary and global aspects of calcium signaling. J Physiol 499:291-306
4. Bootman MD, Berridge MJ, Roderick HL (2002) Calcium signalling: more messengers, more channels, more complexity. Curr Biol 12:R563-R565
5. Carreira RS, Monteiro P, Gon Alves LM, Providencia LA (2006) Carvedilol: just another Beta-blocker or a powerful cardioprotector? Cardiovasc Hematol Disord Drug Targets 6:257-266
6. Chao Y, Shih YL, Chen HJ, Lee SD, Huang TS (1999) Inhibition of DNA synthesis by downregulation of cyclin A but not Skp 2 overexpression in human hepatocellular carcinoma cells. Cancer Lett 139:1-6
7. 2+ concentrations in hepatocytes. Toxicol In Vitro 16:485-490
8. 2+ current in rabbit ventricular myocytes. Eur J Pharmacol 376:189-201
9. 2+ levels in hepatoma cells. Chin J Physiol 43:165-169
10. 2+ regulation in human hepatoma cells. Chin J Physiol 46:117-122
11. Das S, Bhattacharyya S, Ghosh S, Majumdar S (1999) TNF-alpha induced altered signaling mechanism in human neutrophil. Mol Cell Biochem 197:97-108
12. Doughty RN, White HD (2007) Carvedilol: use in chronic heart failure. Expert Rev Cardiovasc Ther 5:21-31
13. Gehr TW, Tenero DM, Boyle DA, Qian Y, Sica DA, Shusterman NH (1999) The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency. Eur J Clin Pharmacol 55:269-277
14. 2+ stores. Cell Calcium 34:241-251
15. 2+ channels. J Gastroenterol Hepatol 19:1128-1134
16. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450
17. Hagmeyer KO, Stein J (2001) Hepatotoxicity associated with carvedilol. Ann Pharmacother 35:1364-1366
18. Harper JL, Camerini-Otero CS, Li AH, Kim SA, Jacobson KA, Daly JW (2003) Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem Pharmacol 65:329-338
19. 2+ levels in human hepatoma cells. Life Sci 72:2571-2580
20. 2+ channel currents of Kupffer cells after hepatic ischemia/reperfusion injury in rats. World J Gastroenterol 12:4694-4698
21. Kajiwara K, Yanagita T, Nakashima Y, Wada A, Izumi F, Yanagihara N (2002) Differential effects of short and prolonged exposure to carvedilol on voltage-dependent Na(+) channels in cultured bovine adrenal medullary cells. J Pharmacol Exp Ther 302:212-218
22. Korantzopoulos P, Galaris D, Papaioannides D, Siogas K (2003) The possible role of oxidative stress in heart failure and the potential of antioxidant intervention. Med Sci Monit 9:RA120-RA125
23. Koshimizu TA, Tsujimoto G, Hirasawa A, Kitagawa Y, Tanoue A (2004) Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. Cardiovasc Res 63:662-672
24. Kramer BK, Ress KM, Erley CM, Risler T (1992) Pharmacokinetic and blood pressure effects of carvedilol in patients with chronic renal failure. Eur J Clin Pharmacol 43:85-88
25. 2+ movement and cytotoxicity in human MG63 osteosarcoma cells. Basic Clin Pharmacol Toxicol 95:59-65
26. 2+ movement in renal tubular cells. Biochem Pharmacol 64:1777-1784
27. Matuszyk J, Kobzdej M, Ziolo E, Kalas W, Kisielow P, Strzadala L (1998) Thymic lymphomas are resistant to Nur77-mediated apoptosis. Biochem Biophys Res Commun 249:279-282
28. 2+ release triggered by NAADP in hepatocyte microsomes. Biochem J 395:233-238
29. Merritt JE, Jacob R, Hallam TJ (1989) Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 264:1522-1527
30. Oldham HG, Clarke SE (1997) In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(-)-carvedilol. Drug Metab Dispos 25:970-977
31. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM et al (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349-1355
32. Pierobon N, Renard-Rooney DC, Gaspers LD, Thomas AP (2006) Ryanodine receptors in liver. J Biol Chem 281:34086-34095
33. Putney JW Jr (1986) A model for receptor-regulated calcium entry. Cell Calcium 7:1-12
34. Quinn T, Molloy M, Smyth A, Baird AW (2004) Capacitative calcium entry in guinea pig gallbladder smooth muscle in vitro. Life Sci 74:1659-1669
35. 2+-permeable channels in animal cells. Handb Exp Pharmacol 179:23-52
36. Spallarossa P, Garibaldi S, Altieri P, Fabbi P, Manca V, Nasti S, Rossettin P, Ghigliotti G, Ballestrero A, Patrone F, Barsotti A, Brunelli C (2004) Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. J Mol Cell Cardiol 37:837-846
37. 2+-ATPase. Proc Natl Acad Sci USA 87:2466-2470
38. Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK (1991) The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. J Biol Chem 266:23856-23862
39. Tsien RY (1980) New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry 19:2396-2404
40. Tunez I, Collado JA, Medina FJ, Munoz MC, Gordillo R, Sampedro C, Moyano MJ, Feijoo M, Muntane J, Montilla P (2006) Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells. Pharmacol Res 54:241-246
41. 2+ mobilization in MG63 human osteosarcoma cells. Horm Res 55:265-270
42. 2+ release mechanism mediated by neither inositol trisphosphate nor ryanodine receptors. Biochem J 361:605-611
43. Yamagata K, Ichinose S, Tagami M (2004) Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Hypertens Res 27:271-282
44. Young RC, Schumann R, Zhang P (2001) Nifedipine block of capacitative calcium entry in cultured human uterine smooth-muscle cells. J Soc Gynecol Investig 8:210-215